
Quarterly Result14 Nov 2026, 04:30 pm
Orchid Pharma Declares Q2 FY27 Financial Results
AI Summary
Orchid Pharma Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company's Board of Directors approved these results, along with the auditors' limited review reports. Key financial figures for the quarter include Net Sales/Income from Operations of ₹34,126.66 Lakhs (₹341.27 Crore) and Total Income of ₹36,989.74 Lakhs (₹369.90 Crore). Expenses for the quarter amounted to ₹33,313.84 Lakhs (₹333.14 Crore), leading to a Profit Before Tax of ₹3,675.93 Lakhs (₹36.76 Crore). The company also reported consolidated figures for the same period.
Key Highlights
- Board approved unaudited standalone & consolidated financial results.
- Quarterly Net Sales stood at ₹34,126.66 Lakhs.
- Profit Before Tax for the quarter was ₹3,675.93 Lakhs.
- Auditors' limited review reports were also approved.
- Results cover both quarterly and half-yearly periods ending Sep 30, 2026.
Price Impact
More from ORCHPHARMA